ENDOLOGIX INC (NASDAQ:ELGX), Down By 5.29% ($0.72) From $13.620 After BUYINS.NET Report Predicted Stock Would Go Down Due To Be
February 17, 2012 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net , a provider of unique trading technologies, released a report on Thursday, February 16th 2012 stating that ENDOLOGIX INC (NASDAQ:ELGX) was expected to go Down due to the Bearish conditions presented in the following report. Click here to view the BUYINS.NET report: http://www.buyins.net/releases/?sym=elgx&id=243813
At the time this story was written, ENDOLOGIX INC (NASDAQ:ELGX) is Down By $0.72 (5.29%) since the BUYINS.NET report was released.
The movement of stock prices in the days and weeks leading to and following specific fundamental or technical events may follow a predictable pattern. Many companies stock price histories show random or unpredictable movements around certain events. But some seem to repeat the same pattern quarter after quarter, year after year. We use powerful computers to uncover those events and correlations to generate predictions with high probabilities of generating very specific returns within very specific time periods.
The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php
ENDOLOGIX INC (NASDAQ:ELGX) - Endologix, Inc. develops, manufactures, markets, and sells minimally invasive treatments for aortic disorders. Its flagship product, the Powerlink System, is an endovascular stent graft for the treatment of abdominal aortic aneurysms, a weakening of the wall of the aorta, an artery in the body. The Powerlink System consists of a self-expanding cobalt chromium alloy stent cage covered with an ePTFE graft; and is implanted in the abdominal aorta, which is accessed through the femoral artery. The Powerlink System shunts away the blood flow from the weakened or aneurysmal section of the aorta, reducing pressure and potential for the aorta to rupture. The Powerlink System includes infrarenal bifurcated systems, and aortic cuffs and limb extensions; and IntuiTrak to deliver and deploy the Powerlink stent graft. Endologix, Inc. sells its products through distributors in the United States, Argentina, Brazil, Chile, Colombia, Germany, Greece, Ireland, Italy, Japan, Mexico, China, and Turkey. The company was formerly known as Radiance Medical Systems, Inc. and changed its name to Endologix, Inc. in May 2002. Endologix, Inc. was founded in 1992 and is based in Irvine, California.
About BUYINS.NET
BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor market-maker surveillance system tracking Level II market-makers in all stocks to determine Price Friction and compliance with new "Fair Market-Making Requirements"
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO
INVESTMENTS & TRADING
SqueezeTrigger -- 30 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
DISCLAIMER:
BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies specifically for this report, but may have been compensated up to $1,200 per month in the past for unrelated data or report services. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.
Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net